Catalent | CTLT - Ordinary Share Capital


Catalent reported $2M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.



Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Bruker USD 151.94M 225K Dec/2025
Centene USD 491.76M 343K Dec/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Cigna USD 263.46M 3.14M Dec/2025
Danaher USD 706.9M 600K Dec/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Elevance Health USD 222.24M 2.94M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
Hologic USD 222.57M 350K Sep/2025
Humana USD 120.59M 318K Dec/2025
Illumina USD 152.8M 900K Dec/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
J&J USD 2.41B 584K Sep/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Lonza CHF 72M 0 Dec/2024
McKesson USD 280M 156M Dec/2025
Merck EUR 434.78M 0 Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Quest Diagnostics USD 110M 1000K Dec/2025
Repligen USD 56.32M 42K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
UnitedHealth USD 905.84M 161K Dec/2025
Veradigm USD 2.79M 4K Sep/2022
Waters USD 98.08M 38.55M Dec/2025
West Pharmaceutical Services USD 72M 100K Dec/2025